The novel treatment of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – providing greater https://tirzepatidepeptide150783.designertoblog.com/73490112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment